• Patent Grants
  • Patents which prove CHA Medical Group’s strength in stem cell research

CHA Medical Group’s advanced stem cell technology

CHA Medical Group has filed the following patents related to stem cell and immunocyte research.

No Patent Grants
26 [KR] Process for preparing lymphocytes comprising activated natural killer cells for targeting cancer cells and pharmaceutical composition comprising the same (Registration number 10-1298012)
25 [KR] Method and composition for proliferating of natural killer cell (Registration number 10-1909879)
24 [JP] Method and composition for proliferating of natural killer cell (Registration number 6073417)
23 [US] Process for isolating vascular endothelial cells from embryoid bodies differentiated from embryonic stem cells (Registration number 7919318)
22 [KR] Process for differentiation of human neural progenitor cells to dopaminergic neurons and medium for differentiation thereof (Registration number 10-1106020)
21 [KR] Method for proliferating neuronal progenitor cells and composition for treating nervous diseases comprising the neuronal progenitor cells (Registration number 10-1662792)
20 [CN] Method for proliferating neuronal progenitor cells and composition for treating nervous diseases comprising the neuronal progenitor cells (Registration number 2985535)
19 [US] Method for proliferating neuronal progenitor cells and composition for treating nervous diseases comprising the neuronal progenitor cells (Registration number 8921107)
18 [EP] Method for proliferating neuronal progenitor cells and composition for treating nervous diseases comprising the neuronal progenitor cells (Registration number 2581443)
17 [JP] Process for differentiation of human neural progenitor cells to dopaminergic neurons and medium for differentiation thereof (Registration number 5776101)

123